Sanity Group Company
%20.jpg)
We believe that everybody deserves to live a healthy life. After decades of scientific negligence of the cannabis plant, more and more research is proving what people already knew thousands of years ago: That cannabis can have a positive impact on peoples’ lives. Therefore, it is our purpose to develop innovative cannabinoid-based pharmaceuticals & wellbeing products and make them widely accessible. To utilize the full potential of its health benefits, Sanity Group is investing in fundamental research of the cannabis plant and its active ingredients as well as in specific areas of application. Equipped with this knowledge, we educate healthcare professionals, patients and consumers and support them to live a healthier life.
Founded Date:
2018-10-01
Last Funding Type:
Series A
Headquarters:
Berlin, Berlin, Germany
Investors Number:
6
Technology:
NeuroTech
Employee Number:
11-50
Industry:
Biotechnology, Community and Lifestyle, Food and Beverage, Health Care, Science and Engineering
Estimated Revenue:
Less than $1M
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Total Funding:
$23.7M